A trial to investigate the efficacy, safety and tolerability of subcutaneous methrotrexate in rheumatoid arthritis patients at St. Gallen Hospital

Trial Profile

A trial to investigate the efficacy, safety and tolerability of subcutaneous methrotrexate in rheumatoid arthritis patients at St. Gallen Hospital

Completed
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2014

At a glance

  • Drugs Methotrexate (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Most Recent Events

    • 14 Jul 2014 New trial record
    • 14 Jun 2014 Results presented at the 15th Annual Congress of the European League Against Rheumatism.
    • 20 May 2014 According to an Antares Pharma media release, the results of this study will be presented at the European League Against Rheumatism Annual Congress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top